These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17574314)

  • 1. Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies.
    Rezaei N; Aghamohammadi A; Siadat SD; Nejati M; Ahmadi H; Moin M; Pourpak Z; Kamali S; Norouzian D; Tabaraei B; Read RC
    Vaccine; 2007 Jul; 25(29):5308-14. PubMed ID: 17574314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults.
    Southern J; Deane S; Ashton L; Borrow R; Goldblatt D; Andrews N; Balmer P; Morris R; Kroll JS; Miller E
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1100-4. PubMed ID: 15539513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of serum bactericidal activity in childhood and adolescence 3-6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine.
    Sakou II; Tzanakaki G; Tsolia MN; Sioumala M; Barbouni A; Kyprianou M; Papaevangelou V; Tsitsika A; Blackwell CC; Kafetzis D; Kremastinou J
    Vaccine; 2009 Jul; 27(33):4408-11. PubMed ID: 19500554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
    Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
    Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children.
    Borrow R; Goldblatt D; Andrews N; Richmond P; Southern J; Miller E
    J Infect Dis; 2001 Aug; 184(3):377-80. PubMed ID: 11443568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of steroid-treated former preterm infants to a single dose of meningococcal C conjugate vaccine.
    Clarke P; Robinson MJ; Ahmad I; Bedford-Russell AR; Connell JE; Powell PJ; Heath PT
    Vaccine; 2006 Apr; 24(16):3273-8. PubMed ID: 16472548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the bactericidal antibody against Neisseria meningitidis serogroup C strains after immunization with a divalent polysaccharide (A plus C) vaccine].
    Xu L; Luo LZ; Zhu BQ; He L; Gao Y; Shao ZJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):619-21. PubMed ID: 19957632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive protection in the infant rat protection assay by sera taken before and after vaccination of teenagers with serogroup B meningococcal outer membrane vesicle vaccines.
    Toropainen M; Saarinen L; Wedege E; Bolstad K; Mäkelä PH; Käyhty H
    Vaccine; 2005 Sep; 23(40):4821-33. PubMed ID: 15970361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses following meningococcal serogroups A, C, Y and W polysaccharide vaccination in C2-deficient persons: evidence for increased levels of serum bactericidal antibodies.
    Brodszki N; Skattum L; Bai X; Findlow H; Borrow R; Jönsson G
    Vaccine; 2015 Apr; 33(15):1839-45. PubMed ID: 25707694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiency.
    Rezaei N; Siadat SD; Aghamohammadi A; Moin M; Pourpak Z; Norouzian D; Mobarakeh JI; Aghasadeghi MR; Nejati M; Read RC
    Clin Vaccine Immunol; 2010 Apr; 17(4):524-8. PubMed ID: 20106999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of bactericidal antibody against Neisseria meningitidis serogroup C in pre-vaccinal era: the Italian epidemiological scenario.
    Gasparini R; Rizzetto R; Sasso T; Rizzitelli E; Manfredi P; Risso D; Gentile C; Ciofi degli Atti M; Panatto D
    Vaccine; 2009 May; 27(25-26):3435-8. PubMed ID: 19200821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based seroprevalence of Neisseria meningitidis serogroup C capsular antibody before the introduction of conjugate vaccine, in Australia.
    Backhouse JL; Gidding HF; MacIntyre CR; McIntyre PB; Gilbert GL
    Vaccine; 2007 Jan; 25(7):1310-5. PubMed ID: 17069937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of immune responses to nasal challenge with meningococcal polysaccharide one year after serogroup-C glycoconjugate vaccination.
    Wing JB; Smart L; Borrow R; Findlow J; Findlow H; Heath AW; Read RC
    Clin Infect Dis; 2011 Jun; 52(11):1317-23. PubMed ID: 21596673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.
    Keyserling H; Papa T; Koranyi K; Ryall R; Bassily E; Bybel MJ; Sullivan K; Gilmet G; Reinhardt A
    Arch Pediatr Adolesc Med; 2005 Oct; 159(10):907-13. PubMed ID: 16203934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of a serologic study after vaccination against serogroup C Neisseria meningitidis in children].
    Espín Ríos MI
    Rev Esp Salud Publica; 2000; 74(4):445-8. PubMed ID: 11031855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune memory in children previously vaccinated with an experimental quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine.
    Pichichero M; Papa T; Blatter M; Mitchell D; Kratz R; Sneed J; Bassily E; Casey J; Gilmet G
    Pediatr Infect Dis J; 2006 Nov; 25(11):995-1000. PubMed ID: 17072120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opsonophagocytosis versus complement bactericidal killing as effectors following Neisseria meningitidis group C vaccination.
    Gomez-Lus ML; Giménez MJ; Vázquez JA; Aguilar L; Anta L; Berrón S; Laguna B; Prieto J
    Infection; 2003 Jan; 31(1):51-4. PubMed ID: 12590334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison on the levels of human serum antibody against Neisseria meningitidis serogroup C measured using serum bactericidal assay and ELISA].
    Zhu BQ; Xu L; Zhou HJ; Shao ZJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 May; 33(5):521-4. PubMed ID: 22883183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
    Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
    Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to conjugated meningococcal C vaccine in pediatric oncology patients.
    Yu JW; Borkowski A; Danzig L; Reiter S; Kavan P; Mazer BD
    Pediatr Blood Cancer; 2007 Dec; 49(7):918-23. PubMed ID: 17366523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.